Sailong Pharmaceutical Group Co., Ltd.

SZSE:002898.SZ

12.44 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Revenue 85.45269.48485.24968.59577.35579.42871.35761.47169.15662.20961.65356.39460.73768.294-6.1638.40956.11232.32478.47442.666106.27266.055110.80596.145138.80290.521114.752106.45799.55643.45378.05753.682
Cost of Revenue 45.46841.87456.636.89736.81236.85246.17227.41524.75524.59824.74419.21217.322.20814.3358.42414.9365.61324.47212.49514.70223.89146.87545.30150.43246.284.9522.97133.69218.1936.07323.088
Gross Profit 39.98427.6128.64931.69740.54442.57625.18534.05744.437.61136.90937.18243.43746.087-20.49529.98541.17626.71154.00230.17191.57142.16563.9350.84488.3744.32129.80183.48665.86425.26341.98430.594
Gross Profit Ratio 0.4680.3970.3360.4620.5240.5360.3530.5540.6420.6050.5990.6590.7150.6753.3270.7810.7340.8260.6880.7070.8620.6380.5770.5290.6370.490.260.7840.6620.5810.5380.57
Reseach & Development Expenses 4.9825.3455.6956.6947.8637.2775.7586.0317.574.1436.4236.0413.9185.039.4416.5055.0964.639.3093.4162.432.4268.5672.9220.0594.696.0824.81212.954020.2790
General & Administrative Expenses -3.78911.152-19.14628.992-3.31710.931-15.2722.963-2.7058.726-12.06220.702-2.8087.883-11.4710.068-4.27110.89-19.1049.968-3.8989.952-13.5287.07-7.74513.55-25.24812.88-6.00812.202-20.47712.905
Selling & Marketing Expenses 23.5815.4544.00810.17422.03720.93134.88415.12726.46622.22740.3217.76627.26728.11311.09123.54527.67412.24334.77717.92157.20824.74533.38324.63844.40923.604-3.9148.46123.0495.0365.8875.162
SG&A 32.34216.606-15.13839.16618.7231.86219.61338.0923.76130.95228.25838.46824.45935.996-0.37933.61323.40323.13315.67327.88953.3134.69719.85631.70836.66437.154-29.15961.34117.04117.238-14.5918.067
Other Expenses -1.128-0.040.234-4.524.0760.29926.33-11.34513.2411.0676.75-2.0631.986-0.13132.848-0.0240.441-1.5410.278-0.142-0.388-0.011-2.5490.022-2.3131.202-7.2411.783.577-0.008-1.6242.186
Operating Expenses 38.45122.40615.73732.88441.75939.43951.70132.77644.57236.16260.31433.47140.71942.04834.54140.20947.10627.48242.41632.67571.35738.09848.10735.92752.1437.9956.6262.86739.90118.12123.64418.618
Operating Income 1.5332.17711.1653.8213.5774.004-33.1431.2815.919-0.512-29.8254.1158.4053.72-27.018-9.717-7.038-3.21310.902-2.84820.7333.70314.39215.80834.8765.11625.38418.67127.8694.88318.32313.201
Operating Income Ratio 0.0180.0310.1310.0560.0460.05-0.4640.0210.086-0.008-0.4840.0730.1380.0544.386-0.253-0.125-0.0990.139-0.0670.1950.0560.130.1640.2510.0570.2210.1750.280.1120.2350.246
Total Other Income Expenses Net -1.273-3.0678.79-0.292-0.151-0-0.6551.69-6.7132.4620.0240.3385.675-0.44927.3020.483-0.667-3.983-0.406-0.4860.131-0.375-1.7670.913-2.431-0.008-3.438-0.1675.449-2.267-0.1073.411
Income Before Tax 0.2592.13711.3993.5293.4254.004-33.7982.971-0.7941.95-29.8014.0488.3943.589-27.734-9.741-6.597-4.75411.18-2.9920.3453.69214.05515.82933.7996.31819.74320.45131.4124.87518.23415.388
Income Before Tax Ratio 0.0030.0310.1340.0510.0440.05-0.4740.048-0.0110.031-0.4830.0720.1380.0534.502-0.254-0.118-0.1470.142-0.070.1910.0560.1270.1650.2440.070.1720.1920.3160.1120.2340.287
Income Tax Expense 0.1190.5136.1892.1923.6350.8065.2122.325-0.5650.6695.3411.6631.0421.52617.919-1.385-0.9462.8082.592-1.6633.2690.5450.4912.9754.9250.7062.176.0520.2173.5362.4582.279
Net Income 0.1411.6245.2091.337-0.213.197-39.0090.645-0.2291.281-35.1422.3857.3522.064-45.653-8.356-5.65-7.5628.587-1.32717.0763.14713.56412.85428.8745.61217.57314.39931.1951.33815.77613.109
Net Income Ratio 0.0020.0230.0610.019-0.0030.04-0.5470.01-0.0030.021-0.570.0420.1210.037.411-0.218-0.101-0.2340.109-0.0310.1610.0480.1220.1340.2080.0620.1530.1350.3130.0310.2020.244
EPS 0.0010.0090.030.008-0.0010.018-0.220.004-0.0010.007-0.20.0140.0420.012-0.26-0.048-0.032-0.0430.049-0.0080.0940.0170.0770.0730.160.0320.10.0820.240.010.120.1
EPS Diluted 0.0010.0090.030.008-0.0010.018-0.220.004-0.0010.007-0.20.0140.0420.012-0.26-0.048-0.032-0.0430.049-0.0080.0940.0170.0770.0730.160.0320.10.0820.240.010.120.1
EBITDA 9.8545.25913.287-5.4673.2842.847-9.783-5.2126.6681.772-16.1521.84313.2614.385-21.841-10.093-5.291-2.48413.008-2.43720.6114.68515.91215.4635.8948.24322.822.49727.3399.42818.50511.999
EBITDA Ratio 0.1150.0760.156-0.080.0420.036-0.137-0.0850.0960.028-0.2620.0330.2180.0643.546-0.263-0.094-0.0770.166-0.0570.1940.0710.1440.1610.2590.0910.1990.2110.2750.2170.2370.224